Your Health, We Care
Release date: 2025-06-06 10:20:10 Article From: Lucius Laos Recommended: 201
Knowing the correct dosage of abuxitinib is critical to improving the effectiveness of treatment.
The standard dose of abuxitinib is 100 mg once daily.
Doctors may adjust the dose on an individual basis, but it is generally not recommended to exceed this range.
For patients with hepatic insufficiency, the dose may need to be halved to 50 mg once daily. In older patients or those who are underweight, doctors may also recommend starting with a lower dose.
If a dose is missed, it should be retaken as soon as you remember, but you should not take a double dose on the same day. Overdose may cause adverse effects and require immediate medical attention.
The cost of treatment is one of the important considerations for patients when choosing a drug.
The market price of abuxitinib is approximately $1,500 per month, and the exact cost may vary by region and where it was purchased.
Some medical insurance plans may cover some of the costs, and patients should check with their insurance company in advance to understand the out-of-pocket ratio and reimbursement conditions.
Some pharmaceutical companies offer patient assistance programs where eligible low-income people may receive discounts on drugs or free treatment opportunities.
The correct use of abuxitinib should be combined with the guidance of the doctor, and the cost of treatment should be paid attention to to ensure the feasibility and effectiveness of long-term treatment.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：3502025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：5512024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：3362025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：3512025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：3262025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：3932025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：3262025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：3002025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
